Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

被引：2
|
作者：
Blackmon, Amanda [1 ]
Danilov, Alexey V. [2 ]
Wang, Lili [3 ]
Pillai, Raju [4 ]
Mirshkarlo, Hormoz Babaei [5 ]
Rosen, Steven T. [6 ]
Siddiqi, Tanya [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1430
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure
    Rozovski, Uri
    Benjamini, Ohad
    Jain, Preetesh
    Thompson, Philip A.
    Wierda, William G.
    O'Brien, Susan
    Burger, Jan A.
    Ferrajoli, Alessandra
    Faderl, Stefan
    Shpall, Elizabeth
    Hosing, Chitra
    Khouri, Issa F.
    Champlin, Richard
    Keating, Michael J.
    Estrov, Zeev
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (14) : 1557 - +
  • [42] Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia
    Gill, Saar
    Vides, Vanessa
    Frey, Noelle, V
    Hexner, Elizabeth O.
    Metzger, Susan
    O'Brien, Megan
    Hwang, Wei-Ting
    Brogdon, Jennifer L.
    Davis, Megan M.
    Fraietta, Joseph A.
    Gaymon, Avery L.
    Gladney, Whitney L.
    Lacey, Simon F.
    Lamontagne, Anne
    Mato, Anthony R.
    Maus, Marcela, V
    Melenhorst, J. Joseph
    Pequignot, Edward
    Ruella, Marco
    Shestov, Maksim
    Byrd, John C.
    Schuster, Stephen J.
    Siegel, Donald L.
    Levine, Bruce L.
    June, Carl H.
    Porter, David L.
    BLOOD ADVANCES, 2022, 6 (21) : 5774 - 5785
  • [43] Phase I Study of a CD19-Directed CAR-T Cell Therapy for Relapsed/Refractory Mantle Cell Lymphomas(MCL)
    Yang, Ping
    Liu, Shuozi
    Zhang, Weilong
    Wang, Jing
    Jing, Hongmei
    BLOOD, 2023, 142
  • [44] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [45] RICHTER'S TRANSFORMATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES
    Gershom, E.
    Huang, S.
    Ye, M. Suhua
    Ahmed, M.
    Gillan, T. L.
    Gerrie, A. S.
    Leitch, H. A.
    Toze, C. L.
    Ramadan, K. M.
    HAEMATOLOGICA, 2014, 99 : 59 - 59
  • [46] Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil
    Donadel, Camila D.
    De Santis, Gil C.
    Goncalves, Thiago E.
    Pires, Bruno G.
    Palma, Leonardo C.
    Gava, Flavia
    Guerino-Cunha, Renato Luiz
    Faria, Joana T. B.
    Silva, Gabriela V. A.
    Darrigo-Junior, Luiz Guilherme
    Fatobene, Giancarlo
    Rocha, Vanderson
    Covas, Dimas T.
    Calado, Rodrigo T.
    Cle, Diego, V
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1040 - 1042
  • [47] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Jin, Xin
    Zhang, Meng
    Sun, Rui
    Lyu, Hairong
    Xiao, Xia
    Zhang, Xiaomei
    Li, Fan
    Xie, Danni
    Xiong, Xia
    Wang, Jiaxi
    Lu, Wenyi
    Zhang, Hongkai
    Zhao, Mingfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [48] Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy
    Yang, Chunmei
    Lei, Wen
    Xie, Hongqiong
    Wu, Gongqiang
    Wei, Juying
    Liang, Aibin
    Qian, Wenbin
    ONCOTARGETS AND THERAPY, 2020, 13 : 12163 - 12168
  • [49] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Xin Jin
    Meng Zhang
    Rui Sun
    Hairong Lyu
    Xia Xiao
    Xiaomei Zhang
    Fan Li
    Danni Xie
    Xia Xiong
    Jiaxi Wang
    Wenyi Lu
    Hongkai Zhang
    Mingfeng Zhao
    Journal of Hematology & Oncology, 15
  • [50] Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, Jiang
    Wang, Gang
    Cheng, Hai
    Wei, Chen
    Qi, Kunming
    Sang, Wei
    Li Zhenyu
    Shi, Ming
    Li, Huizhong
    Qiao, Jianlin
    Pan, Bin
    Zhao, Jing
    Wu, Qingyun
    Zeng, Lingyu
    Niu, Mingshan
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 851 - 858
12345